Fosun Pharma Releases 2025 ESG and Sustainability Report

Bulletin Express04-21

On 21 April 2026, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”) announced that its 2025 Environmental, Social and Governance (ESG) and Sustainability Report is now available in both English and Chinese on the company’s website (www.fosunpharma.com) and on HKEX’s disclosure platform (www.hkexnews.hk).

Shareholders unable to access the online document may obtain a complimentary printed copy by submitting a signed written request to the H-share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.

Further enquiries can be directed to the registrar’s hotline at +852 2980 1333, Monday to Friday, 9:00 a.m. to 6:00 p.m., excluding public holidays.

The notice was issued under the authority of Chairman Chen Yuqing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment